Parathyroid Surgery (Parathyroidectomy)

Parathyroid surgery is among the most rewarding operations in endocrine surgery -- a single, precisely targeted procedure that can cure a systemic metabolic disease affecting bones, kidneys, the gastrointestinal tract, and the nervous system. At THANC Hospital in Chennai, Dr. Vidhyadharan Sivakumar, MCh (Head & Neck Surgery), FEB-ORL HNS, FICRS, Gold Medal in MS (ENT), performs minimally invasive parathyroidectomy with intraoperative PTH monitoring and routine IONM nerve monitoring, combining advanced preoperative localisation with real-time intraoperative confirmation of cure. With training across 8 countries and over 3000 head and neck surgeries, Dr. Vidhyadharan brings the precision and anatomical expertise that parathyroid surgery demands -- operating in a confined space millimetres from the recurrent laryngeal nerves and the thyroid gland itself.

Understanding Parathyroid Disease

The parathyroid glands are four small, lentil-sized endocrine glands located on the posterior surface of the thyroid gland -- two superior and two inferior. Despite their tiny size (each weighing only 30-50 mg), these glands play a critical role in calcium homeostasis. They produce parathyroid hormone (PTH), which regulates serum calcium levels by acting on bones (stimulating calcium release), kidneys (increasing calcium reabsorption and phosphate excretion), and the intestines (enhancing calcium absorption through vitamin D activation).

When one or more parathyroid glands become overactive, the resulting condition -- hyperparathyroidism -- leads to persistently elevated blood calcium levels (hypercalcaemia) that can damage virtually every organ system over time. Primary hyperparathyroidism is the third most common endocrine disorder after diabetes and thyroid disease, affecting approximately 1-7 per 1000 adults, with a strong female predominance (3:1 female to male ratio) and peak incidence in the sixth and seventh decades of life.

In India, primary hyperparathyroidism has historically been underdiagnosed. However, with increasing availability of automated calcium measurement in routine blood panels, the diagnosis is being made more frequently and at earlier stages. Chennai's position as a tertiary referral centre means that THANC Hospital receives patients from across South India, ranging from incidentally detected mild hypercalcaemia to advanced disease with severe skeletal and renal complications.

Understanding the relationship between parathyroid and thyroid conditions is important, as both glands occupy the same anatomical space and may require simultaneous surgical attention. Patients with concurrent thyroid nodules and hyperparathyroidism benefit from a surgeon experienced in both thyroid and parathyroid surgery.

Types and Classification

Primary Hyperparathyroidism

The most common form, caused by intrinsic parathyroid gland pathology:

• Single parathyroid adenoma (80-85%): One gland becomes enlarged and overactive while the other three remain normal and suppressed. This is the ideal indication for minimally invasive focused parathyroidectomy.
• Double adenoma (2-5%): Two glands are independently adenomatous. Requires identification and removal of both abnormal glands.
• Multigland hyperplasia (10-15%): All four glands are enlarged and overactive. Requires bilateral exploration and subtotal parathyroidectomy (3.5-gland removal) or total parathyroidectomy with auto-transplantation.
• Parathyroid carcinoma (<1%): A rare malignancy presenting with markedly elevated calcium (often >14 mg/dL) and very high PTH levels. Requires en bloc resection with the ipsilateral thyroid lobe.

Secondary Hyperparathyroidism

A compensatory response to chronic hypocalcaemia, most commonly caused by chronic kidney disease (CKD). As kidney function declines, phosphate retention, reduced vitamin D activation, and hypocalcaemia stimulate all four parathyroid glands to hypertrophy. Medical management with phosphate binders, active vitamin D, and calcimimetics is the first-line treatment. Surgery (subtotal parathyroidectomy or total parathyroidectomy with auto-transplantation) is reserved for medically refractory cases with severe bone disease, intractable pruritus, calciphylaxis, or very high PTH levels.

Tertiary Hyperparathyroidism

Occurs when chronically stimulated parathyroid glands in secondary hyperparathyroidism develop autonomous function, continuing to overproduce PTH even after the underlying stimulus is corrected (typically after successful kidney transplantation). These glands no longer respond to normal feedback mechanisms and require surgical removal.

Causes and Risk Factors

The causes of hyperparathyroidism vary by type:

Primary hyperparathyroidism risk factors include female sex, age over 50, prior head and neck radiation exposure (which increases parathyroid adenoma risk), lithium therapy (which can stimulate parathyroid cell proliferation), and familial syndromes including Multiple Endocrine Neoplasia type 1 (MEN1) and type 2A (MEN2A), and familial hypocalciuric hypercalcaemia (a benign mimicker that must be excluded before surgery).

Secondary hyperparathyroidism is primarily driven by chronic kidney disease (stages 3-5 and dialysis), chronic vitamin D deficiency, and malabsorption syndromes including coeliac disease and post-bariatric surgery states.

Tertiary hyperparathyroidism develops in patients with longstanding secondary hyperparathyroidism, particularly those on dialysis for extended periods before kidney transplantation. The prolonged stimulation drives clonal expansion of parathyroid cells that become autonomous.

Genetic factors play a significant role in familial forms. MEN1 (menin gene mutation) causes multigland parathyroid hyperplasia along with pituitary and pancreatic tumours. MEN2A (RET gene mutation) associates parathyroid disease with medullary thyroid cancer and phaeochromocytoma. Identifying these syndromes is critical as they alter the surgical approach and mandate screening for associated tumours.

Signs and Symptoms

The clinical manifestations of hyperparathyroidism are classically described as "stones, bones, groans, and psychic moans":

• Stones (renal): Kidney stones (nephrolithiasis) occur in 15-20% of patients with primary hyperparathyroidism. Calcium-containing stones (calcium oxalate and calcium phosphate) are the most common types. Recurrent kidney stones in a young patient should prompt calcium and PTH measurement.
• Bones (skeletal): Osteoporosis, osteopenia, bone pain, and in advanced cases osteitis fibrosa cystica with brown tumours and pathological fractures. Bone density measurement (DEXA scan) typically shows preferential cortical bone loss.
• Groans (gastrointestinal): Abdominal pain, nausea, constipation, anorexia, and peptic ulcer disease. Pancreatitis is a rare but recognised complication of severe hypercalcaemia.
• Psychic moans (neuropsychiatric): Fatigue, depression, anxiety, cognitive impairment ("brain fog"), difficulty concentrating, insomnia, and irritability. These symptoms are often the most debilitating and the most dramatically improved by successful surgery.
• Other manifestations: Muscle weakness (particularly proximal), excessive thirst (polydipsia), frequent urination (polyuria), hypertension, and cardiac arrhythmias in severe cases.

Many patients today are diagnosed with "asymptomatic" hyperparathyroidism detected on routine blood tests. However, careful questioning often reveals subtle symptoms -- fatigue, cognitive difficulties, mood changes -- that patients had attributed to ageing or other causes, and which improve markedly after curative surgery.

Diagnosis at THANC Hospital

Dr. Vidhyadharan follows a structured diagnostic pathway that combines biochemical confirmation, preoperative localisation, and comprehensive assessment of end-organ damage.

Biochemical Confirmation

The diagnosis of primary hyperparathyroidism requires demonstration of elevated or inappropriately normal PTH in the setting of hypercalcaemia. The key investigations include serum calcium (total and ionised), intact PTH, 24-hour urine calcium (to exclude familial hypocalciuric hypercalcaemia), serum phosphate, vitamin D levels, renal function, and alkaline phosphatase. Understanding the broader context of thyroid and parathyroid conditions helps patients navigate the diagnostic process.

Preoperative Localisation

Localisation studies identify the site of the abnormal parathyroid gland(s) before surgery, enabling a focused, minimally invasive approach:

• Sestamibi scan (Tc-99m sestamibi with SPECT/CT): The primary localisation modality. The radioactive tracer is preferentially retained by hyperfunctioning parathyroid tissue. SPECT/CT adds three-dimensional anatomical information, improving sensitivity to 70-90% for single adenomas.
• 4D CT parathyroid protocol: A multiphase contrast-enhanced CT scan that identifies parathyroid adenomas based on their characteristic enhancement pattern -- early arterial uptake with rapid washout. Sensitivity of 80-92%, with superior spatial resolution for identifying small or ectopic glands. Particularly valuable when Sestamibi is negative or discordant.
• High-resolution neck ultrasound: Identifies parathyroid adenomas as hypoechoic, well-defined nodules posterior to the thyroid gland. Sensitivity of 60-80% and provides simultaneous assessment of thyroid pathology. Dr. Vidhyadharan performs this at the initial consultation.

Concordant localisation on two imaging modalities (typically Sestamibi + ultrasound, or Sestamibi + 4D CT) provides high confidence for a minimally invasive focused approach. Discordant or negative imaging raises the possibility of multigland disease and may favour bilateral exploration.

End-Organ Assessment

• DEXA bone density scan: To assess for osteoporosis, with particular attention to the distal radius (cortical bone site preferentially affected by PTH excess).
• Renal ultrasound: To screen for kidney stones and nephrocalcinosis.
• Renal function tests: Creatinine and eGFR to assess kidney function.

How Dr. Vidhyadharan Treats Hyperparathyroidism

Parathyroid surgery demands an intimate understanding of the complex anatomy of the central neck compartment -- the variable positions of parathyroid glands, their relationship to the recurrent laryngeal nerves, the thyroid gland, and the inferior thyroid artery. Dr. Vidhyadharan's MCh super-speciality training in Head & Neck Surgery at the Amrita Institute, his Gold Medal MS (ENT) reflecting mastery of head and neck anatomy, his European Board certification (FEB-ORL HNS), and his international training including microsurgery at Chang Gung Memorial Hospital (Taiwan) and skull base and neck surgery at Royal Adelaide Hospital (Australia) and Toronto General Hospital (Canada) provide the anatomical expertise that complex parathyroid surgery requires.

Minimally Invasive Focused Parathyroidectomy (MIP)

When preoperative localisation concordantly identifies a single parathyroid adenoma, Dr. Vidhyadharan performs minimally invasive focused parathyroidectomy through a 2-3 cm incision. This targeted approach directly accesses the identified abnormal gland, minimises tissue dissection, and reduces operative time to 30-60 minutes. IONM is used to protect the recurrent laryngeal nerve, and intraoperative PTH monitoring confirms biochemical cure before wound closure.

The intraoperative PTH protocol involves drawing blood for PTH measurement before gland excision, then at 5, 10, and 15 minutes after excision. A greater than 50% drop from the highest pre-excision PTH level into the normal range (Miami criteria) confirms that all hyperfunctioning tissue has been removed. This real-time biochemical confirmation achieves cure rates exceeding 97% and eliminates the need to explore the remaining normal glands.

Bilateral Neck Exploration

When localisation studies are negative, discordant, or suggest multigland disease, Dr. Vidhyadharan performs bilateral neck exploration -- identifying all four parathyroid glands and removing only the abnormal ones. This traditional approach requires comprehensive knowledge of parathyroid gland embryology and the numerous anatomical variants of gland position. Ectopic parathyroid glands may be located in the thymus, the carotid sheath, the tracheo-oesophageal groove, within the thyroid gland (intrathyroidal), or in the mediastinum.

Subtotal Parathyroidectomy and Total Parathyroidectomy with Auto-Transplantation

For multigland hyperplasia (common in MEN1 and secondary/tertiary hyperparathyroidism), surgical options include subtotal parathyroidectomy (removing 3.5 glands, leaving a marked remnant) or total parathyroidectomy with auto-transplantation of a small fragment of parathyroid tissue into the forearm muscles. Auto-transplantation preserves parathyroid function while allowing easy monitoring and re-exploration of the graft site if disease recurs.

Special Surgical Scenarios

Concurrent thyroid and parathyroid disease: When a patient has both a parathyroid adenoma and a thyroid nodule requiring surgery, Dr. Vidhyadharan performs simultaneous thyroidectomy and parathyroidectomy, avoiding a second operation.

Reoperative parathyroid surgery: Failed initial parathyroidectomy or recurrent hyperparathyroidism after prior neck surgery presents significant surgical challenges due to scarring and altered anatomy. Dr. Vidhyadharan's experience with revision neck surgery, IONM capability, and access to advanced localisation (4D CT, venous sampling) addresses these complex cases.

Parathyroid carcinoma: Suspected preoperatively when calcium exceeds 14 mg/dL and PTH is markedly elevated. Requires en bloc resection of the parathyroid tumour with the ipsilateral thyroid lobe, avoiding capsule rupture. Dr. Vidhyadharan's oncological training ensures appropriate surgical margins.

For patients seeking detailed cost information for thyroid and parathyroid procedures, our guide to thyroid surgery costs in Chennai provides useful financial context.

What to Expect: Your Treatment Journey

Initial Consultation

Dr. Vidhyadharan reviews your calcium, PTH, and localisation studies, performs a comprehensive neck examination with ultrasound and flexible laryngoscopy, and explains the diagnosis, surgical approach, and expected outcomes. For patients referred with incidentally detected hypercalcaemia, the consultation includes education about hyperparathyroidism and its effects, often explaining symptoms the patient had not previously connected to their calcium levels.

Preoperative Preparation

Patients with severe hypercalcaemia (calcium >12 mg/dL) may require intravenous hydration and medical management before surgery. Localisation studies (Sestamibi and/or 4D CT) are completed if not already done. Preoperative anaesthesia assessment ensures surgical fitness. Medications affecting calcium metabolism are reviewed.

Day of Surgery

Minimally invasive parathyroidectomy is performed under general anaesthesia, though local anaesthesia with sedation is feasible in select cases. The IONM endotracheal tube is placed for nerve monitoring. The identified adenoma is approached through a small, focused incision. Serial PTH samples are drawn and sent for rapid assay. Once the PTH drop confirms cure, the incision is closed. The entire procedure typically takes 30-60 minutes for a focused approach.

Postoperative Care

Calcium levels are monitored in the hours after surgery. Most patients experience a rapid normalisation of calcium levels. "Hungry bone syndrome" -- a temporary drop in calcium levels as calcium-depleted bones rapidly reabsorb calcium after PTH normalisation -- can occur in patients with significant preoperative bone disease and requires calcium and vitamin D supplementation.

Most minimally invasive parathyroidectomy patients are discharged the same day or the following morning. The small incision produces minimal postoperative discomfort. Many patients report subjective improvement in energy, mental clarity, and mood within days of surgery -- often describing a "fog lifting" sensation.

Recovery and Rehabilitation

First Week

The small incision heals rapidly with minimal discomfort. Voice is typically unaffected given the focused surgical approach and IONM protection. Return to desk work and light daily activities is possible within 2-3 days. Calcium and vitamin D supplements are taken as prescribed.

Weeks Two to Four

Full physical activity resumes within 1-2 weeks. Calcium and PTH levels are rechecked at 2-4 weeks to confirm sustained biochemical cure. Vitamin D levels are optimised, as many hyperparathyroidism patients have concurrent vitamin D deficiency that requires correction.

Long-Term Recovery

The long-term benefits of curative parathyroid surgery are substantial:

• Bone density improvement: Studies demonstrate progressive improvement in bone mineral density over 1-5 years after parathyroidectomy, with reductions in fracture risk.
• Kidney stone prevention: Recurrent stone formation ceases in the majority of patients after normalisation of calcium and PTH.
• Neuropsychiatric improvement: Fatigue, depression, cognitive difficulties, and quality of life metrics show significant improvement in multiple studies, with benefits often apparent within weeks of surgery.
• Cardiovascular benefits: Some studies suggest improvement in hypertension and cardiovascular risk markers after parathyroidectomy.

Long-term follow-up includes annual calcium and PTH measurement to confirm sustained cure. Recurrence after successful parathyroidectomy is uncommon (<2-5% over 10 years) and may indicate multigland disease not detected at initial surgery.

Outcomes and Prognosis

Parathyroid surgery at THANC Hospital achieves outcomes consistent with high-volume international centres:

• Cure rate: Greater than 97% for minimally invasive focused parathyroidectomy with intraoperative PTH monitoring. Greater than 95% for bilateral exploration in multigland disease.
• Recurrent laryngeal nerve injury: Less than 1% with routine IONM use and experienced surgical technique.
• Persistent hyperparathyroidism: Less than 2-3%, usually due to unidentified multigland disease or ectopic gland location. Advanced localisation studies and reoperation can achieve cure in the majority of persistent cases.
• Recurrence: Approximately 2-5% over 10 years, predominantly in patients with multigland hyperplasia or familial syndromes (MEN1).
• Quality of life: Published studies consistently demonstrate significant improvement in fatigue, cognitive function, mood, and overall quality of life scores following curative parathyroidectomy.

The prognosis after successful parathyroidectomy is excellent. The metabolic derangements of hyperparathyroidism are reversed, bone density improves progressively, kidney stone risk normalises, and neuropsychiatric symptoms improve -- often dramatically. For patients with secondary or tertiary hyperparathyroidism, surgery controls bone disease and calciphylaxis risk, significantly improving quality of life on dialysis or after transplantation.

Why Choose Dr. Vidhyadharan at THANC Hospital

• MCh Head & Neck Surgery from Amrita Institute -- super-speciality training providing deep expertise in the intricate anatomy of the central neck compartment where parathyroid glands reside.
• Gold Medal MS (ENT) from Annamalai University -- mastery of head and neck surgical anatomy, the foundation of safe parathyroid surgery.
• FEB-ORL HNS (European Board certification) -- the highest European qualification in head and neck surgery, reflecting evidence-based surgical decision-making.
• International training across 8 countries -- including microsurgery at Chang Gung Memorial Hospital (Taiwan), head and neck surgery at Royal Adelaide Hospital (Australia), and skull base surgery at Toronto General Hospital (Canada).
• Over 3000 head and neck surgeries -- the operative volume that provides familiarity with the full spectrum of parathyroid gland anatomical variants and ectopic locations.
• Routine IONM for all parathyroid surgeries -- protecting the recurrent laryngeal nerve in every case, consistent with international thyroid and parathyroid surgery standards.
• Intraoperative PTH monitoring -- providing real-time biochemical confirmation of cure, maximising success rates and minimising unnecessary exploration.
• Comprehensive preoperative localisation -- utilising Sestamibi SPECT/CT, 4D CT, and ultrasound to plan the most focused, minimally invasive approach for each patient.

Cost and Insurance

The cost of parathyroid surgery at THANC Hospital depends on the surgical approach and individual clinical requirements:

• Minimally invasive focused parathyroidectomy: Costs reflect the focused surgical approach, IONM use, intraoperative PTH assays, and typically same-day or one-day hospital stay.
• Bilateral neck exploration: Slightly higher costs due to extended operative time.
• Reoperative parathyroid surgery: Costs may be higher due to the complexity of surgery in a previously operated field and the need for advanced localisation studies.

Most health insurance plans in India -- including CGHS, ECHS, Ayushman Bharat, and private health insurance policies -- cover parathyroid surgery for hyperparathyroidism. THANC Hospital provides transparent cost estimates and assists with insurance documentation and pre-authorisation.

For a personalised assessment and treatment plan, schedule a consultation with Dr. Vidhyadharan Sivakumar at THANC Hospital, Kilpauk, Chennai.

Phone: +91 73059 53378 Location: THANC Hospital, 747 Poonamallee High Road, Kilpauk, Chennai 600010 Book an Appointment

References

1. Wilhelm, S.M., et al. "The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism." JAMA Surgery, 2022.
2. Bilezikian, J.P., et al. "Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop." Journal of Clinical Endocrinology & Metabolism, 2014.
3. Udelsman, R., et al. "One Hundred Consecutive Minimally Invasive Parathyroid Explorations." Annals of Surgery, 2000.
4. Rodgers, S.E., et al. "Intraoperative PTH Monitoring in Parathyroid Surgery." World Journal of Surgery, 2006.
5. Cheung, K., et al. "Systematic Review of Preoperative Parathyroid Localisation." Annals of Surgical Oncology, 2012.
6. National Comprehensive Cancer Network (NCCN). "Neuroendocrine and Adrenal Tumors." NCCN Guidelines.
7. Indian Journal of Endocrinology and Metabolism. "Primary Hyperparathyroidism in India: A Changing Landscape."